This Article Full Text Full Text (PDF) All Versions of this Article: 92/9/3719    most recent Author Manuscript (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gómez-Ambrosi, J. Articles by Frühbeck, G. Search for Related Content PubMed PubMed Citation Articles by Gómez-Ambrosi, J. Articles by Frühbeck, G. Related Collections Metabolism Obesity

Plasma Osteopontin Levels and Expression in Adipose Tissue Are Increased in Obesity

Metabolic Research Laboratory (J.G.-A., V.C., B.R., A.R., G.F.) and Departments of Internal Medicine (I.C.), Endocrinology (C.S., J.S., G.F.), Surgery (F.R., J.A.C.), and Biochemistry (C.M., M.J.G.), Clínica Universitaria de Navarra, University of Navarra, 31008 Pamplona, Spain

Address all correspondence and requests for reprints to: Gema Frühbeck, R.Nutr., M.D., Ph.D., Department of Endocrinology, Clínica Universitaria de Navarra, Avenida Pío XII 36, 31008 Pamplona, Spain. E-mail: gfruhbeck{at}unav.es.

Context: Obesity acts as a cardiovascular risk factor by mechanisms that are not fully understood. Osteopontin (OPN) is a proinflammatory mediator involved in tissue remodeling that plays a role in atherosclerosis and diabetes.

Objective: The aim of the present study was to compare the circulating concentrations of OPN and its mRNA expression in omental adipose tissue of lean, overweight, and obese individuals and to analyze the effect of weight loss.

Subjects and Methods: Plasma concentrations of OPN were measured in 77 volunteers. OPN mRNA expression in omental adipose tissue obtained from 12 women was quantified by real-time PCR. In addition, the concentrations of OPN in 12 obese men were measured before and after weight loss following a dietetic program.

Setting: The study was conducted at a University Hospital.

Results: Obese and overweight patients exhibited significantly increased circulating OPN concentrations as compared with lean subjects (obese 72.6 ± 28.5, overweight 68.2 ± 20.8, lean 42.7 ± 27.9 ng/ml; P < 0.001). A significant positive correlation was found between OPN levels and body fat (r = 0.45; P < 0.0001). Obese individuals showed significantly increased (P < 0.05) mRNA expression of OPN in omental adipose tissue as compared with lean volunteers, which was further increased in obese diabetic patients. Diet-induced weight loss significantly decreased OPN concentrations from 64.7 ± 22.1 to 36.6 ± 20.1 ng/ml (P = 0.006).

Conclusions: These findings represent the first observation that plasma OPN and mRNA expression of OPN in omental adipose tissue are increased in overweight/obese patients with the latter being further elevated in obesity-associated diabetes. Moreover, weight loss reduces OPN concentrations, which may contribute to the beneficial effects accompanying weight reduction. Measurement of OPN might be useful for evaluating the outcomes of various clinical interventions for obesity-related cardiovascular diseases.

This article has been cited by other articles:

				M. Riedl, G. Vila, C. Maier, A. Handisurya, S. Shakeri-Manesch, G. Prager, O. Wagner, A. Kautzky-Willer, B. Ludvik, M. Clodi, et al. Plasma Osteopontin Increases After Bariatric Surgery and Correlates with Markers of Bone Turnover But Not with Insulin Resistance J. Clin. Endocrinol. Metab., June 1, 2008; 93(6): 2307 - 2312. [Abstract] [Full Text] [PDF]

				F. W. Kiefer, M. Zeyda, J. Todoric, J. Huber, R. Geyeregger, T. Weichhart, O. Aszmann, B. Ludvik, G. R. Silberhumer, G. Prager, et al. Osteopontin Expression in Human and Murine Obesity: Extensive Local Up-Regulation in Adipose Tissue but Minimal Systemic Alterations Endocrinology, March 1, 2008; 149(3): 1350 - 1357. [Abstract] [Full Text] [PDF]